Channing Der Archives - UNC Lineberger Comprehensive Cancer Center

September 28, 2026

Newsweek: New Blood Test Shows Promise in Catching One of the Deadliest Cancers Early

Headshots of Channing Der and Jen Jen Yeh

Channing J. Der, PhD, and Jen Jen Yeh, MD, published an editorial contextualizing a landmark clinical study evaluating daraxonrasib, a first-in-class drug targeting KRAS-mutant metastatic pancreatic ductal adenocarcinoma (PDAC).

Tag: Channing Der

Newsweek: New Blood Test Shows Promise in Catching One of the Deadliest Cancers Early

Nature: Landmark pancreatic cancer drug shows potential against lung cancer too

Today: FDA Approves ‘Game-Changing’ Pancreatic Cancer Drug

Unilad: FDA approves ‘landmark’ pancreatic cancer drug that nearly doubles patients’ survival

NBC News: FDA approves ‘game-changing’ pancreatic cancer drug

AAMC: New hope for one of the deadliest cancers

The Washington Post: How scientists found a weakness in one of the the deadliest ‘undruggable’ cancers

The New York Times: How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough

Der, Yeh provide scientific context for recent progress in RAS therapeutics for pancreatic cancer

STAT: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades